HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

James A McAteer Selected Research

Lithotripsy (Extracorporeal Shockwave Lithotripsy)

3/2015Lithotripter outcomes in a community practice setting: comparison of an electromagnetic and an electrohydraulic lithotripter.
6/2013Cavitation-induced streaming in shock wave lithotripsy.
12/2012Size and location of defects at the coupling interface affect lithotripter performance.
11/2012Evaluation of shock wave lithotripsy injury in the pig using a narrow focal zone lithotriptor.
9/2012Fragility of brushite stones in shock wave lithotripsy: absence of correlation with computerized tomography visible structure.
5/2011Shock wave technology and application: an update.
12/2009Shock wave lithotripsy: advances in technology and technique.
10/2009Extracorporeal shock wave lithotripsy at 60 shock waves/min reduces renal injury in a porcine model.
3/2009Treatment protocols to reduce renal injury during shock wave lithotripsy.
2/2009Assessment of renal injury with a clinical dual head lithotriptor delivering 240 shock waves per minute.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


James A McAteer Research Topics

Disease

28Shock
03/2015 - 01/2002
6Kidney Calculi (Kidney Stone)
10/2013 - 06/2003
6Urinary Calculi (Urinary Calculus)
10/2013 - 05/2004
6Calculi (Calculus)
09/2012 - 11/2003
3Infections
10/2013 - 10/2010
3Wounds and Injuries (Trauma)
02/2009 - 10/2002
2Long Term Adverse Effects
03/2009 - 03/2008
1Diabetes Mellitus
03/2008
1Primary Hyperoxaluria (Oxaluria, Primary)
01/2006
1Hemorrhage
10/2002
1Nephrolithiasis
01/2002
1Pathologic Processes
01/2002

Drug/Important Bio-Agent (IBA)

7Calcium OxalateIBA
09/2013 - 06/2003
6MineralsIBA
09/2012 - 06/2003
3StruviteIBA
10/2013 - 06/2003
3Cystine (L-Cystine)IBA
12/2007 - 06/2003
2ApatitesIBA
10/2013 - 01/2007
2dihydrate dibasic calcium phosphate (brushite)IBA
09/2012 - 06/2003
2salicylhydroxamic acid (SHAM)IBA
02/2009 - 10/2002
2Adenine phosphoribosyltransferase deficiencyIBA
01/2006 - 01/2002
22,8-dihydroxyadenineIBA
01/2006 - 01/2002
1CarbonatesIBA
10/2013
1Calcium Sulfate (Alabaster)IBA
12/2005
1Contrast MediaIBA
09/2005
1DiamondIBA
12/2004
1Durapatite (Hydroxylapatite)IBA
06/2003
1Uric Acid (Urate)IBA
06/2003
1brassIBA
10/2002
1Indicators and Reagents (Reagents)IBA
10/2002
1Messenger RNA (mRNA)IBA
01/2002
1Adenine PhosphoribosyltransferaseIBA
01/2002
1Complementary DNA (cDNA)IBA
01/2002

Therapy/Procedure

30Lithotripsy (Extracorporeal Shockwave Lithotripsy)
03/2015 - 01/2002
1Microbubbles
06/2013
1Therapeutics
12/2012
1Aftercare (After-Treatment)
11/2012
1Transjugular Intrahepatic Portasystemic Shunt
10/2002